P443 Magnetic resonance imaging after ligation of the intersphincteric fistula tract for high perianal fistulas in Crohn’s disease: a retrospective cohort study
ECCO'20 Vienna
2020
P444 The impact of azathioprine on inflammatory bowel disease patients’ overall health-related quality of life: a single-centre retrospective cohort study
ECCO'20 Vienna
2020
P446 Transcriptional and microbial biomarkers of response to anti-TL1A therapy in ulcerative colitis: the Phase 2a TUSCANY study
ECCO'20 Vienna
2020
P447 No severe neonatal and maternal complications in inflammatory bowel diseases patients treated with ustekinumab or vedolizumab during pregnancy
ECCO'20 Vienna
2020
P448 Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extension
ECCO'20 Vienna
2020
P449 Systematic review with meta-analysis: risk of lymphoma associated with anti-tumour necrosis factor (TNF) agents in inflammatory bowel disease
ECCO'20 Vienna
2020
P451 Short-and long-term effectiveness of ustekinumab in patients with Crohn’s disease: real-world data from a German IBD cohort
ECCO'20 Vienna
2020
P452 Biologic use patterns and predictors for non-persistence and switching of biologics in patients with inflammatory bowel disease: a nationwide population-based study
ECCO'20 Vienna
2020
P454 Serum oncostatin M predicts mucosal healing in Crohn’s disease patients treated with infliximab
ECCO'20 Vienna
2020
P455 Adherence to enteral nutrition therapy by adults with active Crohn’s disease is associated with conscientiousness personality trait
ECCO'20 Vienna
2020
P458 Association between adalimumab serum levels and level of remission in Crohn’s disease
ECCO'20 Vienna
2020
P459 The impact of latent cytomegalovirus infection on the disease behaviour in patients with ulcerative colitis
ECCO'20 Vienna
2020
P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis
ECCO'20 Vienna
2020